Memantine Therapy for Multiple Sclerosis (Memantine-MS)

This study has been terminated.
(Unexpected side-effects: reversible and mild to moderate neurological impairment)
Sponsor:
Collaborator:
H. Lundbeck A/S
Information provided by (Responsible Party):
Clinica Universidad de Navarra, Universidad de Navarra
ClinicalTrials.gov Identifier:
NCT00638833
First received: March 12, 2008
Last updated: June 7, 2012
Last verified: June 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: March 2008
  Primary Completion Date: March 2008 (Final data collection date for primary outcome measure)
No publications provided by Clinica Universidad de Navarra, Universidad de Navarra

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):